Seven-Year Surveillance and AI-Based Forecasting of Antimicrobial Resistance in Pediatric Escherichia coli Infections in Northern China (2018-2024)

中国北方地区儿童大肠杆菌感染抗菌药物耐药性的七年监测及基于人工智能的预测(2018-2024)

阅读:4

Abstract

BACKGROUND: Pediatric Escherichia coli infections are a major cause of morbidity, and increasing antimicrobial resistance (AMR) complicates empirical treatment. Long-term local surveillance combined with trend forecasting may support rational antimicrobial use and stewardship in northern China. METHODS: We retrospectively analyzed 2021 pediatric E. coli isolates collected at Baoding Hospital of Beijing Children's Hospital, Capital Medical University (2018-2024), calculated annual resistance rates to 14 commonly used antibiotics and the prevalence of extended-spectrum β-lactamase (ESBL) producers, defined an overall resistance indicator as the mean annual resistance across these agents, and used χ (2)-tests, linear regression, and autoregressive integrated moving average (ARIMA) and long short-term memory (LSTM) models to evaluate temporal trends and generate exploratory forecasts for 2025-2027. RESULTS: Nearly half of isolates were from children <2 years and about two-thirds from boys; pus, sputum, and urine were the predominant specimen types. Resistance to ampicillin and trimethoprim-sulfamethoxazole remained high, whereas resistance to several β-lactams, including ampicillin/sulbactam and third-generation cephalosporins, declined significantly over time. ESBL-producing isolates accounted for 45.93% of all strains, with annual detection rates >50% in 2018-2020 and around 40% thereafter, while carbapenems and amikacin maintained very low resistance rates. Both ARIMA and LSTM models suggested a modest further decline in the overall resistance indicator through 2027, with LSTM showing slightly better fit and lower prediction errors. CONCLUSION: Pediatric E. coli isolates in our center exhibited high resistance to several common oral agents but encouraging declines in ESBL prevalence and cephalosporin resistance, likely reflecting local antimicrobial stewardship. Exploratory AI-based time-series models may help anticipate resistance trajectories and support pediatric antibiotic policies and stewardship, although forecasts from a short annual series should be interpreted cautiously.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。